Pharmaceutical & Biotechnology Environment Monitoring Market Trends

  • Report ID: 3931
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Pharmaceutical & Biotechnology Environment Monitoring Market - Growth Drivers and Challenges

Growth Drivers

  • Increasing Demand for Artificial Intelligence and Information Technology- The usage of cloud technology including private and public cloud, increased emphasis on the value of research and development, precision medicine, and other digital processes are about to undergo some dramatic developments in the pharmaceutical and biotechnology environment monitoring industry. The pharmaceutical and biotechnology industries may now work together with several different stakeholders for the same market thanks to cloud technology. According to a survey, 98% of all respondent businesses have a multi-cloud strategy in place or in development. Additionally, the cloud will host 82% of the workload.

  • Rising Need for Cold Storage Solutions- The pharmaceutical and biotechnology industries have benefited from R&D for the treatment of COVID-19 since the primary vaccine developed required a safe cold storage solution service. The necessity for cold chain services to assist in the monitoring and transportation of the vaccinations and other pertinent goods to their destination was great.

  • Increasing Requirement for Storage and Delivery Services- The delivery of goods by sea and air is another factor boosting the development of this industry. Such a need can be seen as a result of lower long-term average ocean and air freight costs, which may be coupled with an increase in demand from biologics, temperature-sensitive pharmaceuticals, and other protein segments. 

Challenges-

  • Concerns About Health and Safety Might Change Market Dynamics- In the pharmaceutical and biotechnology industries, health and safety are crucial for long-term viability and increased output. Biological and chemical risks, which have been shown to represent a major threat to those working in these settings, are mostly exposed in this business.  Along with this, a lack of safety regulations and non-compliance may affect employee productivity and, in the long run, have an adverse effect on the expansion of the organization.

  • Researchers are Few in Undeveloped Countries

  • Rising Costs Across the Business

Base Year

2025

Forecast Year

2026-2035

CAGR

6.6%

Base Year Market Size (2025)

USD 1.23 billion

Forecast Year Market Size (2035)

USD 2.33 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of pharmaceutical & biotechnology environment monitoring is assessed at USD 1.3 billion.

The global pharmaceutical & biotechnology environment monitoring market size was valued at more than USD 1.23 billion in 2025 and is expected to register a CAGR of over 6.6%, exceeding USD 2.33 billion revenue by 2035.

The Asia Pacific region is anticipated to capture a 35% share by 2035 in the pharmaceutical & biotechnology environment monitoring market, spurred by the rapid adoption of advanced biotechnology and rising investment in regional biotech enterprises.

Key players in the market include Thermo Fisher Scientific Company, Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos